Literature DB >> 19753578

Trends in catheter ablation for atrial fibrillation in the United States.

Patrick P Kneeland1, Margaret C Fang.   

Abstract

BACKGROUND: There are few data on the use of catheter ablation for atrial fibrillation (AF) in the United States. We analyzed data from the National Hospital Discharge Survey (NHDS) to examine trends in the rate of catheter ablation for hospitalized patients with AF over a 15-year period.
OBJECTIVE: To examine rates of catheter ablation in patients with AF over time.
DESIGN: All adult patients in the NHDS with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for AF from the years 1990 to 2005 were identified and assessed for the presence of a cardiac catheter ablation procedure code. Clinical characteristics associated with ablation were identified and multivariable logistic regression used to determine trends in the rate of ablation therapy over time.
RESULTS: We identified 269,471 adults with AF. The rate of catheter ablation in AF patients increased from 0.06% in 1990 to 0.79% in 2005 (P < 0.001 for trend). Compared to those not undergoing ablation, ablated patients were younger (mean age 66 versus 76 years; P < 0.001), more likely to be male (57% versus 43%; P < 0.001), have private insurance (22% versus 11%; P < 0.001), and have a none of the following stroke risk factors: congestive heart failure, hypertension, age >75 years, diabetes mellitus, or stroke/transient ischemic attack (37% versus 16%; P < 0.001). Catheter ablation in AF patients increased by 15% per year over the time period (95% confidence interval [CI], 13%-16%) and across all age groups, including in patients age > or =80 years (0.0% in 1990 and 0.26% in 2005; P < 0.001 for trend).
CONCLUSIONS: The rate of catheter ablation in patients with AF is increasing significantly over time, even in the oldest patients. Medicine. Copyright 2009 Society of Hospital

Entities:  

Mesh:

Year:  2009        PMID: 19753578      PMCID: PMC2919218          DOI: 10.1002/jhm.445

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  29 in total

1.  Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis.

Authors:  M A Wood; C Brown-Mahoney; G N Kay; K A Ellenbogen
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

Review 2.  Progress in nonpharmacologic therapy of atrial fibrillation.

Authors:  Douglas L Packer; Sam Asirvatham; Thomas M Munger
Journal:  J Cardiovasc Electrophysiol       Date:  2003-12

Review 3.  Catheter ablation for atrial fibrillation.

Authors:  Mark D O'Neill; Pierre Jaïs; Mélèze Hocini; Frédéric Sacher; George J Klein; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2007-09-25       Impact factor: 29.690

4.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

Authors:  Simon Stewart; Carole L Hart; David J Hole; John J V McMurray
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

5.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

8.  Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

Authors:  H J Crijns; I C Van Gelder; W H Van Gilst; H Hillege; A M Gosselink; K I Lie
Journal:  Am J Cardiol       Date:  1991-08-01       Impact factor: 2.778

9.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

10.  Cost of care distribution in atrial fibrillation patients: the COCAF study.

Authors:  Jean-Yves Le Heuzey; Olivier Paziaud; Olivier Piot; Mina Ait Said; Xavier Copie; Thomas Lavergne; Louis Guize
Journal:  Am Heart J       Date:  2004-01       Impact factor: 4.749

View more
  28 in total

1.  Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.

Authors:  Prashant D Bhave; Xin Lu; Saket Girotra; Hooman Kamel; Mary S Vaughan Sarrazin
Journal:  Heart Rhythm       Date:  2015-03-23       Impact factor: 6.343

2.  Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.

Authors:  João Mesquita; Diogo Cavaco; António Miguel Ferreira; Francisco Moscoso Costa; Pedro Carmo; Francisco Morgado; Miguel Mendes; Pedro Adragão
Journal:  J Interv Card Electrophysiol       Date:  2018-03-06       Impact factor: 1.900

Review 3.  Iatrogenic atrial septal defect: reassurance or inquisitiveness.

Authors:  Niyada Naksuk; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2018-04-22       Impact factor: 1.900

Review 4.  Source Determination in Atrial Fibrillation.

Authors:  Rakesh Latchamsetty; Fred Morady
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

5.  Evolution of Force Sensing Technologies.

Authors:  Dipen Shah
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 6.  Is AF Ablation Cost Effective?

Authors:  William Martin-Doyle; Matthew R Reynolds
Journal:  J Atr Fibrillation       Date:  2010-08-23

7.  Increasing the Single-Procedure Success Rate of Pulmonary Vein Isolation.

Authors:  Mattias Duytschaever; Mark O'Neill; Martin Martinek
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

8.  Airway trauma in a high patient volume academic cardiac electrophysiology laboratory center.

Authors:  Zhe Yan; Jonathan W Tanner; David Lin; Ara A Chalian; Joseph S Savino; Lee A Fleisher; Renyu Liu
Journal:  Anesth Analg       Date:  2012-12-07       Impact factor: 5.108

9.  Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes.

Authors:  Alan Sugrue; Christopher V DeSimone; Charles J Lenz; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2015-12-09       Impact factor: 1.900

10.  Fluoroless catheter ablation in adults: a single center experience.

Authors:  J Mauricio Sánchez; Margaret A Yanics; Patricia Wilson; Amit Doshi; Thomas Kurian; Stephen Pieper
Journal:  J Interv Card Electrophysiol       Date:  2016-01-05       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.